Literature DB >> 13677501

Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis.

C Green1, G Kiebert, C Murphy, J D Mitchell, M O'Brien, A Burrell, P N Leigh.   

Abstract

Motor neurone disease (MND) has a severe impact on patient quality of life, especially in later stages of the disease. This study assesses the health-related quality of life (HRQL) of MND patients, and for the first time elicits health state values from patients for their present health state. A structured interview was conducted with 77 patients. Patients completed a disease specific health status measure (ALSAQ-40), a generic health status measure (EuroQol EQ-5D), a visual analogue scale (VAS) and a standard gamble (SG) exercise. The ALSAQ-40 was sensitive to disease severity. Patients' mean VAS rating of their own health ranged from 0.74 for stage 1 (early) disease severity (n = 15), to 0.37 for stage 4 (late stage) disease severity (n = 19). Utilities elicited via SG varied from a mean of 0.79 for stage 1 disease severity to a mean of 0.45 for stage 4 disease severity. The EQ-5D derived single index ranged from a mean of 0.63 for stage 1 disease severity to a mean of -0.01 for stage 4 disease severity. This study demonstrates that it is feasible and practical to obtain health state values from MND patients and it provides evidence that patients place a high value on their HRQL, even in cases where health status is very poor.

Entities:  

Mesh:

Year:  2003        PMID: 13677501     DOI: 10.1023/a:1025052609818

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

Review 1.  A review of the use of health status measures in economic evaluation.

Authors:  J Brazier; M Deverill; C Green; R Harper; A Booth
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

Review 2.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

3.  Valuing health states: a comparison of methods.

Authors:  P Dolan; C Gudex; P Kind; A Williams
Journal:  J Health Econ       Date:  1996-04       Impact factor: 3.883

Review 4.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

5.  Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.

Authors:  C Jenkinson; R Fitzpatrick; C Brennan; M Bromberg; M Swash
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

6.  Improvement in quality of life after lung transplantation: a preliminary study. The University of Washington Medical Center Lung Transplant Study Group.

Authors:  S D Ramsey; D L Patrick; S Lewis; R K Albert; G Raghu
Journal:  J Heart Lung Transplant       Date:  1995 Sep-Oct       Impact factor: 10.247

7.  An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole.

Authors:  M Riviere; V Meininger; P Zeisser; T Munsat
Journal:  Arch Neurol       Date:  1998-04

8.  Incorporating societal concerns for fairness in numerical valuations of health programmes.

Authors:  E Nord; J L Pinto; J Richardson; P Menzel; P Ubel
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

9.  Whose preferences count?

Authors:  P Dolan
Journal:  Med Decis Making       Date:  1999 Oct-Dec       Impact factor: 2.583

10.  Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures.

Authors:  C Jenkinson; A Gray; H Doll; K Lawrence; S Keoghane; R Layte
Journal:  Med Care       Date:  1997-11       Impact factor: 2.983

View more
  11 in total

1.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

Review 2.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Health-related quality of life and supportive care in patients with rare long-term neurological conditions.

Authors:  Melanie Calvert; Hardev Pall; Thomas Hoppitt; Benjamin Eaton; Edward Savill; Catherine Sackley
Journal:  Qual Life Res       Date:  2012-09-23       Impact factor: 4.147

4.  Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI).

Authors:  Deepa Rao; Seung W Choi; David Victorson; Rita Bode; Amy Peterman; Allen Heinemann; David Cella
Journal:  Qual Life Res       Date:  2009-04-25       Impact factor: 4.147

5.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

6.  Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.

Authors:  Qian-Qian Wei; Yanbing Hou; Yongping Chen; Ruwei Ou; Bei Cao; Lingyu Zhang; Tianmi Yang; Huifang Shang
Journal:  Health Qual Life Outcomes       Date:  2021-07-20       Impact factor: 3.186

7.  Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.

Authors:  Hosein Shamshiri; Mohammad Reza Eshraghian; Nastaran Ameli; Shahriar Nafissi
Journal:  Iran J Neurol       Date:  2013

8.  The predictive value of early acute kidney injury for long-term survival and quality of life of critically ill patients.

Authors:  Ivo W Soliman; Jos F Frencken; Linda M Peelen; Arjen J C Slooter; Olaf L Cremer; Johannes J van Delden; Diederik van Dijk; Dylan W de Lange
Journal:  Crit Care       Date:  2016-08-03       Impact factor: 9.097

9.  "When I saw walking I just kind of took it as wheeling": interpretations of mobility-related items in generic, preference-based health state instruments in the context of spinal cord injury.

Authors:  Yvonne Anne Michel; Lidia Engel; Kim Rand-Hendriksen; Liv Ariane Augestad; David Gt Whitehurst
Journal:  Health Qual Life Outcomes       Date:  2016-11-28       Impact factor: 3.186

10.  Do Generic Preference-Based Measures Accurately Capture Areas of Health-Related Quality of Life Important to Individuals with Amyotrophic Lateral Sclerosis: A Content Validation Study.

Authors:  Nicole Peters; Vanina Dal Bello-Haas; Tara Packham; Marvin Chum; Colleen O'Connell; Wendy S Johnston; Joy C MacDermid; John Turnbull; Jill Van Damme; Ayse Kuspinar
Journal:  Patient Relat Outcome Meas       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.